Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-03
1995-04-25
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546118, C07D47114, A61K 3144
Patent
active
054099366
ABSTRACT:
An imidazopyridine derivative is disclosed of the formula [I]: ##STR1## wherein R.sup.1 is lower alkyl, R.sup.2 is a group of the formula ##STR2## where Z is oxygen atom, R.sup.0 is lower alkyl, R.sup.3 is carboxyl or lower alkoxycarbonyl and Ring A is tetrazolyl-substituted or unsubstituted phenyl, and pharmaceutically acceptable salt thereof, that are useful in prophylaxis and treatment of hypertension.
REFERENCES:
patent: 4812462 (1989-03-01), Blankley et al.
patent: 4816463 (1989-03-01), Blankley et al.
patent: 5091390 (1992-02-01), Ardecky et al.
Journal of Heterocyclic Chemistry, vol. 28, pp. 97-108 (1991); S. Klutchko et al.
C. J. Blankley et al, Journal of Medicinal Chemistry; vol. 34, No. 11, (Nov. 1991); pp. 3248-3260.
Honma Yasushi
Naito Kazuaki
Narita Hiroshi
Nomura Sumihiro
Sekine Yasuo
Henley III Raymond
Spivak Phyllis G.
Tanabe Seiyaku Co. Ltd.
LandOfFree
Imidazopyridine derivatives for the treatment of hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazopyridine derivatives for the treatment of hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyridine derivatives for the treatment of hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1568033